Pitching Financial Times Medical Reporters: Vertical Press Strategy
The FT's medical coverage sits at the intersection of science, capital, and policy. Pitches that ignore the business dimension rarely survive the first filter.
This guide gives you a repeatable system for reaching Financial Times Medical reporters with angles built for their readers: investors, executives, and regulators.
Editorial Scope: What Financial Times Covers in Medical#
The FT treats medical stories as market and policy stories. Drug pricing, M&A, reimbursement, and health-system economics outrank pure clinical findings.
Expect coverage of pharma pipelines, biotech financing, medtech, public health policy, and the business of care delivery. Lifestyle-wellness pitches belong elsewhere.
A credible pitch names the commercial or regulatory stake in the first two sentences. If you can't, reframe before sending.
Identifying Active Writers on the Financial Times Medical Reporters List#
The beat is broad and split across desks—pharma, health policy, and personal finance all touch medical. Target the writer whose recent bylines match your story's economic lens.
Use a maintained Financial Times Medical reporters list to map specialization before outreach. Our directory names Amy Austin, Isabel Berwick, Niamh Rowe, and Jude Webber as representative writers; verify current focus against their latest pieces.
💡 Vertical Pro Tip: Before pitching any of the Financial Times Medical journalists, read their last three articles and cite one specific angle in your subject line—beat writers reward evidence you've done the homework.
Angles & Data Points That Resonate With Financial Times Medical Journalists#
Lead with proprietary numbers: market sizing, pricing differentials, trial economics, or reimbursement timelines. The FT runs on exclusive data, not press-release claims.
Strong angles include cross-border regulatory divergence, capital flows into biotech, and cost-of-care comparisons. Offer an exclusive dataset or first-look analysis.
Financial Times Medical journalists respond to spokespeople who can speak to strategy and valuation—CEOs, CFOs, and health economists beat pure researchers.
| Factor | Recommended Strategy | What Gets Ignored |
|---|---|---|
| Story hook | Market, policy, or capital impact | Pure clinical efficacy claims |
| Data | Exclusive datasets, proprietary analysis | Generic press-release stats |
| Spokesperson | CEO, CFO, health economist | Unavailable or junior experts |
| Timing | Tie to earnings, regulation, M&A cycles | Evergreen "awareness" pitches |
| Exclusivity | Offer a first-look or exclusive | Mass-blast distributions |
Outreach Protocols & Accessing Financial Times Medical Journalists Contacts#
Email is the default channel; keep it under 150 words with the news in line one. Attach nothing on first contact—offer data on request.
Build Financial Times Medical journalists contacts from bylines, official FT staff pages, and verified directories—never scraped personal addresses. Respect embargoes precisely; the FT enforces them.
Follow up once after 48–72 hours, then move on. Persistence without new information damages the relationship.
Fast-Action Pitch Checklist for Medical#
- Confirm the writer's current beat and recent coverage.
- State the market, policy, or financial stake in sentence one.
- Include one exclusive data point or first-look offer.
- Name a senior, media-trained spokesperson with availability.
- Keep the email under 150 words; no attachments on first send.
- Verify contact via official or directory sources before sending.
Run this checklist before every pitch to the Financial Times Medical reporters—discipline, not volume, earns the reply.